S&P 500   5,075.71 (-0.05%)
DOW   38,910.91 (-0.16%)
QQQ   435.42 (-0.50%)
AAPL   181.32 (-0.72%)
MSFT   406.66 (-0.20%)
META   484.91 (-0.44%)
GOOGL   136.19 (-1.94%)
AMZN   173.16 (-0.22%)
TSLA   203.67 (+1.97%)
NVDA   776.15 (-1.38%)
NIO   5.46 (-5.54%)
AMD   175.07 (-1.65%)
BABA   75.14 (-3.27%)
T   16.99 (+0.95%)
F   12.27 (+2.25%)
MU   89.70 (-2.34%)
CGC   3.51 (-0.57%)
GE   154.77 (+0.51%)
DIS   110.47 (+0.96%)
AMC   5.07 (+5.41%)
PFE   27.12 (+0.86%)
PYPL   60.47 (+0.52%)
XOM   105.34 (+1.26%)
S&P 500   5,075.71 (-0.05%)
DOW   38,910.91 (-0.16%)
QQQ   435.42 (-0.50%)
AAPL   181.32 (-0.72%)
MSFT   406.66 (-0.20%)
META   484.91 (-0.44%)
GOOGL   136.19 (-1.94%)
AMZN   173.16 (-0.22%)
TSLA   203.67 (+1.97%)
NVDA   776.15 (-1.38%)
NIO   5.46 (-5.54%)
AMD   175.07 (-1.65%)
BABA   75.14 (-3.27%)
T   16.99 (+0.95%)
F   12.27 (+2.25%)
MU   89.70 (-2.34%)
CGC   3.51 (-0.57%)
GE   154.77 (+0.51%)
DIS   110.47 (+0.96%)
AMC   5.07 (+5.41%)
PFE   27.12 (+0.86%)
PYPL   60.47 (+0.52%)
XOM   105.34 (+1.26%)
S&P 500   5,075.71 (-0.05%)
DOW   38,910.91 (-0.16%)
QQQ   435.42 (-0.50%)
AAPL   181.32 (-0.72%)
MSFT   406.66 (-0.20%)
META   484.91 (-0.44%)
GOOGL   136.19 (-1.94%)
AMZN   173.16 (-0.22%)
TSLA   203.67 (+1.97%)
NVDA   776.15 (-1.38%)
NIO   5.46 (-5.54%)
AMD   175.07 (-1.65%)
BABA   75.14 (-3.27%)
T   16.99 (+0.95%)
F   12.27 (+2.25%)
MU   89.70 (-2.34%)
CGC   3.51 (-0.57%)
GE   154.77 (+0.51%)
DIS   110.47 (+0.96%)
AMC   5.07 (+5.41%)
PFE   27.12 (+0.86%)
PYPL   60.47 (+0.52%)
XOM   105.34 (+1.26%)
S&P 500   5,075.71 (-0.05%)
DOW   38,910.91 (-0.16%)
QQQ   435.42 (-0.50%)
AAPL   181.32 (-0.72%)
MSFT   406.66 (-0.20%)
META   484.91 (-0.44%)
GOOGL   136.19 (-1.94%)
AMZN   173.16 (-0.22%)
TSLA   203.67 (+1.97%)
NVDA   776.15 (-1.38%)
NIO   5.46 (-5.54%)
AMD   175.07 (-1.65%)
BABA   75.14 (-3.27%)
T   16.99 (+0.95%)
F   12.27 (+2.25%)
MU   89.70 (-2.34%)
CGC   3.51 (-0.57%)
GE   154.77 (+0.51%)
DIS   110.47 (+0.96%)
AMC   5.07 (+5.41%)
PFE   27.12 (+0.86%)
PYPL   60.47 (+0.52%)
XOM   105.34 (+1.26%)

Hoth Therapeutics (HOTH) Earnings Date, Estimates & Call Transcripts

$1.29
+0.02 (+1.57%)
(As of 10:48 AM ET)
Skip Charts & View Estimated and Actual Earnings Data

HOTH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HOTH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Hoth Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.43) EPS
Next Year EPS Consensus Estimate: ($1.69) EPS

HOTH Earnings Date and Information

Hoth Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off prior year's report dates.

Hoth Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/29/2024
Estimated)
------- 
11/13/2023Q3 2023-($0.60)($0.60)($0.60)--
8/11/2023Q2 2023-($0.57)($0.57)($0.57)--
5/15/2023Q1 2023-($0.88)($0.88)($0.88)--
3/31/2023Q4 2022-($2.72)($2.72)($2.72)--
11/10/2022Q3 2022-($2.05)($2.05)($2.05)--
8/12/2022Q2 2022-($2.25)($2.25)($0.09)--
5/12/2022Q1 2022-($2.75)($2.75)($0.11)--
3/30/2022Q4 2021-($3.50)($3.50)($0.14)--
11/10/2021Q3($3.3750)($3.50)($0.1250)($0.14)--
8/11/2021Q2 2021($4.50)($3.50)+$1.00($0.14)--
5/13/2021Q1 2021-($6.00)($6.00)($0.24)--
3/16/2021Q4 2020-($1.00)($1.00)($0.04)--












Hoth Therapeutics Earnings - Frequently Asked Questions

When is Hoth Therapeutics's earnings date?

Hoth Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates. Learn more on HOTH's earnings history.

How much profit does Hoth Therapeutics generate each year?

Hoth Therapeutics (NASDAQ:HOTH) has a recorded net income of -$11.37 million. HOTH has generated -$4.77 earnings per share over the last four quarters.

What is Hoth Therapeutics's EPS forecast for next year?

Hoth Therapeutics's earnings are expected to grow from ($2.43) per share to ($1.69) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:HOTH) was last updated on 2/28/2024 by MarketBeat.com Staff